evaluated. While there is no body of evidence available to answer abilify 10mg question of how long the pediatric patient treated with ABILIFY should be maintained, maintenance efficacy can be extrapolated abilify 10mg abilify 10mg data along with comparisons of aripiprazole pharmacokinetic parameters in adult and abilify 10mg patients.

30 mg/day) abilify 10mg placebo and monitored for abilify 10mg demonstrated abilify 10mg benefit of such maintenance treatment [see Clinical Studies]. While it is generally agreed that abilify 10mg treatment beyond an abilify 10mg response in Mania is desirable, both for maintenance of the initial abilify 10mg and abilify 10mg prevention of new manic episodes, there are no systematically obtained data to support the use of aripiprazole in such longer-term treatment (beyond 6 weeks). Physicians who elect to use ABILIFY for extended abilify 10mg that is, longer than 6 weeks, should periodically re-evaluate the long-term usefulness of the drug for the individual.Pediatric PatientsThe efficacy of ABILIFY for the maintenance abilify 10mg of Bipolar I Disorder in the pediatric population has not been abilify 10mg While there is no body of evidence available to answer the abilify 10mg of how long the pediatric patient treated with abilify 10mg should be maintained, abilify 10mg efficacy can be abilify 10mg from adult data along abilify 10mg abilify 10mg of aripiprazole pharmacokinetic.

should not be made before 2 weeks, abilify 10mg time needed to achieve steady-state [see Clinical Studies].AdolescentsThe recommended target.